MORGAN THELEN: Open Payments
NPI 1568228989 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,118 in 221 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $4,905 · 2025 $6,118
Food & beverage: $6,011Education: $107
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 24 | $839 |
| Galderma Laboratories, L.P. | 18 | $758 |
| ABBVIE INC. | 17 | $456 |
| Novartis Pharmaceuticals Corporation | 12 | $453 |
| UCB, Inc. | 20 | $437 |
| Regeneron Healthcare Solutions, Inc. | 18 | $379 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 18 | $357 |
| Amgen Inc. | 11 | $354 |
| Arcutis Biotherapeutics, Inc. | 18 | $336 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $295 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, TREMFYA, COSENTYX, OTEZLA, Zoryve, RINVOQ.
Industry payments across TX — which companies pay providers there.
